Big Pharma Tries to Monopolize CBD Oil Market
西府来子 (2018-01-28 00:44:53) 评论 (0)Story at-a-glance
- The cannabinoids in cannabis — cannabidiol (CBD) and tetrahydrocannabinol (THC) — work by way of naturally occurring cannabinoid receptors embedded in cell membranes throughout your body
- The fact that your body is replete with cannabinoid receptors, key to so many biological functions, is why there's such enormous medical potential for cannabis
- South Dakota has rescheduled CBD from a Schedule I to a Schedule IV substance by excluding it from the definition of marijuana
- GW Pharmaceuticals failed in its efforts to restrict Schedule IV classification to FDA approved CBD products only, which prevented the company from creating a monopoly in South Dakota
- The legal status of CBD oil as a nutritional supplement is now threatened by drug companies seeking FDA approval for CBD-containing drugs
评论 (0)
目前还没有任何评论
西府来子 名博